Ilumya – Psoriasis – NOV Display Banners HCP Wallboard Extension- Tier 1 – 34944

For many clinicians who treat patients with psoriasis, achieving 2022 revenue goals has been challenging. London-based consulting firm Censuswide polled chief financial officers (CFOs) and revenue cycle vice presidents (VPs) in...

For psoriasis, which affects up to 5% of the Western population, topical drugs are still the preferred treatment for cases of mild-to-severe disease activity or as a supplement to systemic or biologic anti-psoriatic drugs,...

There appears to be a causal effect between inflammatory bowel disease (IBD) and psoriasis and psoriatic arthritis, according to a study published in JAMA Dermatology. Researchers examined the link between IBD and psoriasis or...

The FDA has approved spesolimab-sbzo as the first treatment for generalized pustular psoriasis (GPP) flares in adults. The agent is a novel, selective antibody infusion that blocks the activation of the interleukin-36 receptor,...

Doctors often feel as if everyone who is not a doctor is judging them. The result is that once a complaint process starts, doctors tend to turn into their own worst enemies. The goal is to be alert to a situation starting and...

Along with increased expenses, a growing number of labor shortages have severely affected many healthcare organizations, resulting in poor financial performance, causing great concern for many dermatologists and other healthcare...